• 11/26/2024

AstraZeneca, Pfizer Agree Rare-Disease Deal

Wall Street Journal

AstraZeneca’s Alexion unit has completed a purchase and license agreement for an early-stage rare-disease gene therapy portfolio from Pfizer for $1 billion.

https://www.wsj.com/articles/astrazenecas-rare-disease-unit-buy-pfizer-portfolio-for-1-bln-6fec24fb